American Society For Transplantation And Cellular Therapy | WebDisclosure

Basculer en Français

8295	Companies
114810	Keywords
55260	Articles
62423	Press releases

Headlines Articles Press releases American Society For Transplantation And Cellular Therapy

Home
Companies
American Society For Transplantation And Cellular Therapy

BRIEF

published on 11/11/2024 at 18:05, 9 days 15 hours ago

Réunions en tandem de 2025 pour réunir des experts à Hawaï

Thérapie Cellulaire Et Génique Progrès Médicaux Transplantation De Cellules Hématopoïétiques Réunions En Tandem ASTCT Et CIBMTR
BRIEF

published on 11/11/2024 at 18:05, 9 days 15 hours ago

2025 Tandem Meetings to Convene Experts in Hawai'i

Tandem Meetings Hematopoietic Cell Transplantation Medical Advancements Cellular And Gene Therapy ASTCT And CIBMTR
PRESS RELEASE

published on 11/11/2024 at 18:00, 9 days 15 hours ago

The Tandem Meetings of ASTCT and CIBMTR Return to Hawai'i From February 12-15, 2025
ASTCT and CIBMTR unite leading experts at the Tandem Meetings to share advancements in HCT, cellular therapy, and gene therapy with a global community of professionals. Event highlights latest scientific updates and innovative technologies

Cellular Therapy Gene Therapy Tandem Meetings HCT Scientific Updates
BRIEF

published on 08/15/2024 at 19:05, 3 months 5 days ago

FDA Approves Axatilimab-Csfr for Chronic Graft-Versus-Host Disease

FDA Approval ASTCT Axatilimab-csfr CGVHD Treatment AGAVE-201 Study
BRIEF

published on 08/15/2024 at 19:05, 3 months 5 days ago

La FDA approuve l'axatilimab-Csfr pour le traitement de la maladie chronique du greffon contre l'hôte

ASTCT Approbation De La FDA Axatilimab-csfr Traitement De La GVHD Chronique Etude AGAVE-201
PRESS RELEASE

published on 08/15/2024 at 19:00, 3 months 5 days ago

ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
ASTCT applauds FDA approval of Niktimvo by Incyte Corporation for cGVHD treatment. Study confirms efficacy and potential benefits for patients. ASTCT remains committed to advancing transplantation field

FDA Approval ASTCT Transplantation CGVHD Treatment Niktimvo
BRIEF

published on 08/02/2024 at 22:15, 3 months 18 days ago

La FDA approuve TECELRA pour le traitement du sarcome synovial

ASTCT Thérapie Cellulaire Approbation De La FDA TECELRA Sarcome Synovial
BRIEF

published on 08/02/2024 at 22:15, 3 months 18 days ago

FDA Approves TECELRA for Synovial Sarcoma Treatment

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
PRESS RELEASE

published on 08/02/2024 at 22:10, 3 months 18 days ago

American Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma Treatment
The FDA's accelerated approval of TECELRA marks a milestone in cancer treatment. ASTCT supports this advance in cellular therapy for synovial sarcoma patients

FDA Approval Cellular Therapy ASTCT Synovial Sarcoma TECELRA
BRIEF

published on 04/10/2024 at 16:05, 7 months 10 days ago

ASTCT Endorses FDA's New CAR T-Cell Therapy Approvals for Multiple Myeloma

FDA Approval Medical Innovation Multiple Myeloma CAR T-cell Therapy ASTCT Endorsement

Accesswire

Published on 11/21/2024 at 09:00, 56 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 21 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 31 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 56 minutes ago

Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 56 minutes ago

Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 09:41, 15 minutes ago

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Buy
Published on 11/21/2024 at 09:01, 55 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 08:59, 56 minutes ago

Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 56 minutes ago

Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 41 minutes ago

EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.

Les Echos

Published on 11/21/2024 at 06:58, 2 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 58 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 49 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 36 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE